Top Biotechnology & Medical Research stocks in Australia

Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.

Name
Market Cap
Price to Earnings
TTM
Dividend Yield
% TTM
au flag iconTLXTelix PharmaceuticalsAU$9.12bn145.56n/a
au flag iconMSBMesoblastAU$2.39bnn/an/a
au flag iconCU6Clarity PharmaceuticalsAU$843.73mn/an/a
au flag iconOPTOptheaAU$738.75mn/an/a
au flag iconPYCPYC TherapeuticsAU$723.24mn/an/a
au flag iconIMMImmutepAU$414.84mn/an/a
au flag iconIMUImugeneAU$267.82mn/an/a
au flag iconDXBDimerixAU$256.62mn/an/a
au flag iconCGSCogstateAU$244.13m21.02n/a
au flag iconRACRace OncologyAU$217.14mn/an/a
au flag iconPARParadigm BiopharmaceuticalsAU$163.56mn/an/a
au flag iconALAArovella TherapeuticsAU$105.94mn/an/a
au flag iconLTPLtr PharmaAU$103.16mn/an/a
au flag iconAGNArgenica TherapeuticsAU$96.07mn/an/a
au flag iconACWActinogen MedicalAU$93.98mn/an/a
au flag iconPIQProteomics International LaboratoriesAU$63.54mn/an/a
au flag iconGD8GO-DX (Aust)AU$61.94mn/an/a
au flag iconBXNBioxyneAU$55.33m20.45n/a
au flag iconATHAlterity TherapeuticsAU$53.20mn/an/a
au flag iconCYPCynata TherapeuticsAU$49.55mn/an/a